Annexin A2 and A5 Serve As New Ligands for C1q on Apoptotic Cells

Overview

Journal J Biol Chem

Specialty Biochemistry

Date 2012 Aug 11

PMID 22879587

Citations 52

Authors

Myriam Martin

Jonatan Leffler

Anna M Blom

Affiliations

Soon will be listed here.

Abstract

C1q is the initiator of the classical complement pathway and opsonizes apoptotic cells to facilitate phagocytosis. Deficiency of C1q is the strongest known risk factor for development of systemic lupus erythematosus (SLE), which appears to be related to ensuing impaired clearance of apoptotic material. The objective of the current study was to investigate new ligands for C1q on the surface of apoptotic cells. We revealed that the two phospholipid-binding proteins annexin A2 and A5 are, beside DNA, significant C1q ligands. We furthermore, demonstrated that C1q binds directly to histones exposed on the surface of dying cells but we did not detect significant interaction with phosphatidylserine. The complement inhibitors C4b-binding protein and factor H also interact with dying cells, most likely to decrease complement activation beyond the level of C3 to allow noninflammatory clearance. Despite the fact that C4b-binding protein, factor H, and C1q share some ligands on dying cells, we showed that these three proteins did not compete with one another for binding to apoptotic cells. We additionally demonstrated that the way in which apoptosis is induced influenced both the degree of apoptosis and the binding of C1q. The knowledge, that annexin A2 and A5 act as ligands for C1q on apoptotic cells, sheds new light on the pathophysiology of autoimmune diseases.

Citing Articles

Nonapoptotic caspase-3 guides C1q-dependent synaptic phagocytosis by microglia.

Andoh M, Shinoda N, Taira Y, Araki T, Kasahara Y, Takeuchi H Nat Commun. 2025; 16(1):918.

PMID: 39843445 PMC: 11754728. DOI: 10.1038/s41467-025-56342-7.

Complement activation drives the phagocytosis of necrotic cell debris and resolution of liver injury.

Vandendriessche S, Mattos M, Bialek E, Schuermans S, Proost P, Marques P Front Immunol. 2025; 15:1512470.

PMID: 39759517 PMC: 11696981. DOI: 10.3389/fimmu.2024.1512470.

Annexin A2 in Tumors of the Gastrointestinal Tract, Liver, and Pancreas.

Christofidis K, Pergaris A, Fioretzaki R, Charalampakis N, Kapetanakis E, Kavantzas N Cancers (Basel). 2024; 16(22).

PMID: 39594718 PMC: 11592865. DOI: 10.3390/cancers16223764.

Efferocytosis and Respiratory Disease.

Zheng W, Zhou Z, Guo X, Zuo X, Zhang J, An Y Int J Mol Sci. 2023; 24(19).

PMID: 37834319 PMC: 10573909. DOI: 10.3390/ijms241914871.

ANXA2 is a potential biomarker for cancer prognosis and immune infiltration: A systematic pan-cancer analysis.

Ning Y, Li Y, Wang H Front Genet. 2023; 14:1108167.

PMID: 36713082 PMC: 9877333. DOI: 10.3389/fgene.2023.1108167.

References

Fraser D, Pisalyaput K, Tenner A . C1q enhances microglial clearance of apoptotic neurons and neuronal blebs, and modulates subsequent inflammatory cytokine production. J Neurochem. 2009; 112(3):733-43. PMC: 2809134. DOI: 10.1111/j.1471-4159.2009.06494.x. View

Baruah P, Simpson E, Dumitriu I, Derbyshire K, Coe D, Addey C . Mice lacking C1q or C3 show accelerated rejection of minor H disparate skin grafts and resistance to induction of tolerance. Eur J Immunol. 2010; 40(6):1758-67. PMC: 2988415. DOI: 10.1002/eji.200940158. View

Nauta A, Bottazzi B, Mantovani A, Salvatori G, Kishore U, Schwaeble W . Biochemical and functional characterization of the interaction between pentraxin 3 and C1q. Eur J Immunol. 2003; 33(2):465-73. DOI: 10.1002/immu.200310022. View

Ao W, Zheng H, Chen X, Shen Y, Yang C . Anti-annexin II antibody is associated with thrombosis and/or pregnancy morbidity in antiphospholipid syndrome and systemic lupus erythematosus with thrombosis. Rheumatol Int. 2010; 31(7):865-9. DOI: 10.1007/s00296-010-1379-4. View

Paques E, Huber R, PRIESS H, Wright J . Isolation of the globular region of the subcomponent q of the C1 component of complement. Hoppe Seylers Z Physiol Chem. 1979; 360(2):177-83. DOI: 10.1515/bchm2.1979.360.1.177. View

Buttke T, Sandstrom P . Oxidative stress as a mediator of apoptosis. Immunol Today. 1994; 15(1):7-10. DOI: 10.1016/0167-5699(94)90018-3. View

Kask L, Trouw L, Dahlback B, Blom A . The C4b-binding protein-protein S complex inhibits the phagocytosis of apoptotic cells. J Biol Chem. 2004; 279(23):23869-73. DOI: 10.1074/jbc.C400159200. View

Elward K, Griffiths M, Mizuno M, Harris C, Neal J, Morgan B . CD46 plays a key role in tailoring innate immune recognition of apoptotic and necrotic cells. J Biol Chem. 2005; 280(43):36342-54. DOI: 10.1074/jbc.M506579200. View

Trouw L, Bengtsson A, Gelderman K, Dahlback B, Sturfelt G, Blom A . C4b-binding protein and factor H compensate for the loss of membrane-bound complement inhibitors to protect apoptotic cells against excessive complement attack. J Biol Chem. 2007; 282(39):28540-28548. DOI: 10.1074/jbc.M704354200. View

10.

Bengtsson A, Nezlin R, Shoenfeld Y, Sturfelt G . DNA levels in circulating immune complexes decrease at severe SLE flares-correlation with complement component C1q. J Autoimmun. 1999; 13(1):111-9. DOI: 10.1006/jaut.1999.0300. View

11.

Hrycek A, Cieslik P . Annexin A5 and anti-annexin antibodies in patients with systemic lupus erythematosus. Rheumatol Int. 2011; 32(5):1335-42. DOI: 10.1007/s00296-011-1793-2. View

12.

Ogden C, deCathelineau A, Hoffmann P, Bratton D, Ghebrehiwet B, Fadok V . C1q and mannose binding lectin engagement of cell surface calreticulin and CD91 initiates macropinocytosis and uptake of apoptotic cells. J Exp Med. 2001; 194(6):781-95. PMC: 2195958. DOI: 10.1084/jem.194.6.781. View

13.

Tenner A, Lesavre P, Cooper N . Purification and radiolabeling of human C1q. J Immunol. 1981; 127(2):648-53. View

14.

Lood C, Gullstrand B, Truedsson L, Olin A, Alm G, Ronnblom L . C1q inhibits immune complex-induced interferon-alpha production in plasmacytoid dendritic cells: a novel link between C1q deficiency and systemic lupus erythematosus pathogenesis. Arthritis Rheum. 2009; 60(10):3081-90. DOI: 10.1002/art.24852. View

15.

Baroni M, Pavani G, Marescotti D, Kaabache T, Borgel D, Gandrille S . Membrane binding and anticoagulant properties of protein S natural variants. Thromb Res. 2009; 125(2):e33-9. DOI: 10.1016/j.thromres.2009.09.015. View

16.

Ricklin D, Hajishengallis G, Yang K, Lambris J . Complement: a key system for immune surveillance and homeostasis. Nat Immunol. 2010; 11(9):785-97. PMC: 2924908. DOI: 10.1038/ni.1923. View

17.

Trouw L, Nilsson S, Goncalves I, Landberg G, Blom A . C4b-binding protein binds to necrotic cells and DNA, limiting DNA release and inhibiting complement activation. J Exp Med. 2005; 201(12):1937-48. PMC: 2212022. DOI: 10.1084/jem.20050189. View

18.

Hayes M, Moss S . Annexins and disease. Biochem Biophys Res Commun. 2004; 322(4):1166-70. DOI: 10.1016/j.bbrc.2004.07.124. View

19.

Vandivier R, Ogden C, Fadok V, Hoffmann P, Brown K, Botto M . Role of surfactant proteins A, D, and C1q in the clearance of apoptotic cells in vivo and in vitro: calreticulin and CD91 as a common collectin receptor complex. J Immunol. 2002; 169(7):3978-86. DOI: 10.4049/jimmunol.169.7.3978. View

20.

Mihlan M, Stippa S, Jozsi M, Zipfel P . Monomeric CRP contributes to complement control in fluid phase and on cellular surfaces and increases phagocytosis by recruiting factor H. Cell Death Differ. 2009; 16(12):1630-40. DOI: 10.1038/cdd.2009.103. View